ArticlePharmaceutics2026

Desmocollin-3 Is a Novel Target Receptor for Targeted Drug Delivery for Malignant Prostate Cancer.

Vipin Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.